N3-Methyladenine Induces Early Poly(ADP-Ribosylation), Reduction of Nuclear Factor-κB DNA Binding Ability, and Nuclear Up-Regulation of Telomerase Activity

doi:10.1124/MOL.104.004937

Paper

N3-Methyladenine Induces Early Poly(ADP-Ribosylation), Reduction of Nuclear Factor-κB DNA Binding Ability, and Nuclear Up-Regulation of Telomerase Activity

Published Feb 1, 2005 · L. Tentori, Olindo Forini, E. Fossile

Molecular Pharmacology

Q1 SJR score

14

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Methylation of N3-adenine represents a novel pharmacological strategy for the treatment of resistant tumors. However, little is known about the biochemical pathways involved in cell death induced by N3-methyladenine. In the present study, we show that MeOSO2 (CH2)2-lexitropsin (Me-Lex), a compound generating almost exclusively N3-methyladenine (>99%), provoked a burst of poly(ADP-ribosylation) and loss of mitochondrial membrane potential in leukemia cells. These events were followed by a marked decrease in nuclear poly(ADP-ribose) polymerase-1 (PARP-1) expression and nuclear factor-κB (NF-κB) activity. Moreover, DNA damage generated by N3-methyladenine induced a marked decrease in telomerase in the cytosol that was accompanied by a transient up-regulation of activity in the nucleus, as a consequence of nuclear translocation of telomerase in response to genotoxic damage. PARP-1 inhibition blocked ADP-ribose polymer formation, preserved mitochondrial membrane integrity, and counteracted the reduction of NF-κB activity, thus preventing the appearance of necrosis. On the other hand, because PARP-1 is a component of the base excision repair (BER), the combination of Me-Lex + PARP-1 inhibitor triggered apoptosis as a result of disruption of BER process. In conclusion, the present study provides new insight into the cellular response to N3-adenine-selective methylating agents that can be exploited for the treatment of tumors unresponsive to classical wide-spectrum methylating agents. Moreover, the results underline the central and paradoxical role of PARP-1 in cell death induced by N3-methyladenine: effector of necrosis and coordinator of methylpurine repair.

In Vitro Study

Study Snapshot

N3-methyladenine-selective methylating agents can treat resistant tumors by inducing cell death and highlighting the central role of PARP-1 in cell death.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

N3-Methyladenine Induces Early Poly(ADP-Ribosylation), Reduction of Nuclear Factor-κB DNA Binding Ability, and Nuclear Up-Regulation of Telomerase Activity

Sign up to use Study Snapshot

References

Poly(ADP-ribose) Polymerase-1-mediated Cell Death in Astrocytes Requires NAD+ Depletion and Mitochondrial Permeability Transition*

NAD+ depletion and mitochondrial permeability transition are necessary steps in PARP-1-mediated cell death in astrocytes, linking activation to AIF translocation and cell death.

Introduction of Human Telomerase Reverse Transcriptase to Normal Human Fibroblasts Enhances DNA Repair Capacity

hTERT/telomerase enhances DNA repair activities in normal human oral fibroblasts, potentially by recruiting repair proteins to damaged DNA sites.

The biological effects of N3‐methyladenine

N3-methyladenine selectively methylates DNA, halting DNA polymerase and initiating cell death, potentially offering a promising cancer therapy without causing toxic or mutagenic side effects.

Transcriptional Coactivation of Nuclear Factor-κB-dependent Gene Expression by p300 Is Regulated by Poly(ADP)-ribose Polymerase-1*

PARP-1 and p300 work synergistically to regulate NF-B-dependent gene expression in response to TNF and LPS, playing an essential role in inflammation and cell survival.

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Systemic administration of GPI 15427 significantly enhances temozolomide's antitumor efficacy against solid or hematological neoplasias, even in the central nervous system.

Citations

Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.

This study developed a classification system for chemoxenobiotics based on predicted conserved biophysical properties, which can improve the effectiveness of existing combination chemotherapy regimens and predict personalized cancer treatment outcomes.

Calorimetric studies of the interactions of linker histone H1(0) and its carboxyl (H1(0)-C) and globular (H1(0)-G) domains with calf-thymus DNA.

Linker histone H1 and H1-C domains bind tightly to DNA, with a small electrostatic contribution to binding, and DNA restructuring occurs during complex formation.

Comparative Kinetics of Escherichia coli- and Staphylococcus aureus-Specific Activation of Key Immune Pathways in Mammary Epithelial Cells Demonstrates That S. aureus Elicits a Delayed Response Dominated by Interleukin-6 (IL-6) but Not by IL-1A or Tumor Necrosis Factor Alpha

Staphylococcus aureus infections in the udder cause milder inflammation and persisting infections, while E. coli infections cause acute inflammation and strong bactericidal factors.

Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB.

Placenta growth factor plays a role in melanoma cell resistance to temozolomide through activation of the transcription factor NF-B.

XRCC1 deficiency influences the cytotoxicity and the genomic instability induced by Me-lex, a specific inducer of N3-methyladenine.

XRCC1 deficiency can lead to genomic instability even without an exogenous genotoxic insult, and low levels of Me-lex-induced lesions can exacerbate this instability.